Literature DB >> 17112575

Some rewarding effects of androgens may be mediated by actions of its 5alpha-reduced metabolite 3alpha-androstanediol.

Cheryl A Frye1.   

Abstract

The abuse of anabolic-androgenic steroids (AS) is a growing problem; however, the effects and mechanisms underlying their addictive effects are not well understood. Research findings regarding androgen abuse in people and hedonic effects of androgens in laboratory rats are reviewed. Androgens, like other steroids, can have traditional actions via cognate intracellular steroid receptors, as well as other substrates. Our recent results indicate that testosterone (T) metabolites may have actions in part via gamma-aminobutyric acid (GABA)(A)/benzodiazepine receptor complexes (GBRs) and/or dopaminergic neurons in the nucleus accumbens, to mediate T's positive hedonic states. This may provide the basis for positive reinforcing effects of androgen seeking and use behavior. Following a comprehensive review of the background literature, our findings are presented that have explored the extent to which metabolites of T mediate euphorogenic effects of androgens by acting in the nucleus accumbens. Then results regarding whether GBRs are necessary substrates for androgens' positive hedonic effects are discussed. Lastly, research that addresses if dopaminergic neurons in the nucleus accumbens are necessary for these effects of androgens are discussed. This review provides a comprehensive examination of the hedonic properties and abuse/addiction potential of androgens and the putative mechanisms underlying these effects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17112575      PMCID: PMC1857333          DOI: 10.1016/j.pbb.2006.10.003

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  110 in total

1.  The use of testosterone in the treatment of depressions.

Authors:  M D ALTSCHULE; K J TILLOTSON
Journal:  N Engl J Med       Date:  1948-12-30       Impact factor: 91.245

2.  Anabolic steroid dependence.

Authors:  L R Hays; S Littleton; V Stillner
Journal:  Am J Psychiatry       Date:  1990-01       Impact factor: 18.112

3.  Anabolic-androgenic steroid dependence.

Authors:  K J Brower; F C Blow; T P Beresford; C Fuelling
Journal:  J Clin Psychiatry       Date:  1989-01       Impact factor: 4.384

4.  Anabolic androgenic steroids and suicide.

Authors:  K J Brower; F C Blow; G A Eliopulos; T P Beresford
Journal:  Am J Psychiatry       Date:  1989-08       Impact factor: 18.112

5.  Anabolic steroid dependence with opioid-type features.

Authors:  F Tennant; D L Black; R O Voy
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

6.  Test violent offenders for anabolic steroid use.

Authors:  J W Orchard; J P Best
Journal:  Med J Aust       Date:  1994-08-01       Impact factor: 7.738

7.  Benzodiazepine withdrawal delirium with catatonic features. Occurrence in patients with partial seizure disorders.

Authors:  P Hauser; O Devinsky; M De Bellis; W H Theodore; R M Post
Journal:  Arch Neurol       Date:  1989-06

8.  Expression of testosterone conditioned place preference is blocked by peripheral or intra-accumbens injection of alpha-flupenthixol.

Authors:  M G Packard; J P Schroeder; G M Alexander
Journal:  Horm Behav       Date:  1998-08       Impact factor: 3.587

9.  Effects of the androgenic/anabolic steroid stanozolol on GABAA receptor function: GABA-stimulated 36Cl- influx and [35S] TBPS binding.

Authors:  A E Masonis; M P McCarthy
Journal:  J Pharmacol Exp Ther       Date:  1996-10       Impact factor: 4.030

Review 10.  Anabolic-androgenic steroids. Current issues.

Authors:  C E Yesalis; M S Bahrke
Journal:  Sports Med       Date:  1995-05       Impact factor: 11.136

View more
  23 in total

1.  The testosterone metabolite 3α-diol enhances female rat sexual motivation when infused in the nucleus accumbens shell.

Authors:  Eliana L Sánchez Montoya; Lizaida Hernández; Jennifer L Barreto-Estrada; José G Ortiz; Juan Carlos Jorge
Journal:  J Sex Med       Date:  2010-11       Impact factor: 3.802

Review 2.  Adverse effects of 5α-reductase inhibitors: What do we know, don't know, and need to know?

Authors:  Abdulmaged M Traish; Roberto Cosimo Melcangi; Marco Bortolato; Luis M Garcia-Segura; Michael Zitzmann
Journal:  Rev Endocr Metab Disord       Date:  2015-09       Impact factor: 6.514

3.  In the ventral tegmental area, progestogens' membrane-mediated actions for lordosis of rats involve the second-messenger phospholipase C.

Authors:  Cheryl A Frye; Alicia A Walf
Journal:  Brain Res       Date:  2008-07-16       Impact factor: 3.252

4.  Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2009-04-01       Impact factor: 4.492

5.  CYP7B1 Enzyme Deletion Impairs Reproductive Behaviors in Male Mice.

Authors:  Mario G Oyola; Damian G Zuloaga; David Carbone; Anna M Malysz; Alexandra Acevedo-Rodriguez; Robert J Handa; Shaila K Mani
Journal:  Endocrinology       Date:  2015-04-07       Impact factor: 4.736

6.  National Athletic Trainers' Association position statement: anabolic-androgenic steroids.

Authors:  Robert D Kersey; Diane L Elliot; Linn Goldberg; Gen Kanayama; James E Leone; Mike Pavlovich; Harrison G Pope
Journal:  J Athl Train       Date:  2012 Sep-Oct       Impact factor: 2.860

7.  Male risk taking, female odors, and the role of estrogen receptors.

Authors:  Martin Kavaliers; Amy Clipperton-Allen; Cheryl L Cragg; Jan-Åke Gustafsson; Kenneth S Korach; Louis Muglia; Elena Choleris
Journal:  Physiol Behav       Date:  2012-03-27

Review 8.  Illicit anabolic-androgenic steroid use.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Horm Behav       Date:  2009-09-18       Impact factor: 3.587

Review 9.  Anabolic-androgenic steroid dependence: an emerging disorder.

Authors:  Gen Kanayama; Kirk J Brower; Ruth I Wood; James I Hudson; Harrison G Pope
Journal:  Addiction       Date:  2009-12       Impact factor: 6.526

Review 10.  Reflexive testosterone release: a model system for studying the nongenomic effects of testosterone upon male behavior.

Authors:  John G Nyby
Journal:  Front Neuroendocrinol       Date:  2007-10-01       Impact factor: 8.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.